Role of IFITM2 in osteogenic differentiation of C3H10T1/2 mesenchymal stem cells

Yongtao Zhang1, Xiangdong Li2, Shanshan Zhang1

  • 1Key Laboratory for Biotech Drugs of the National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shandong, China.

PubMed

Insights

Interferon-inducible transmembrane protein 2 (IFITM2) promotes osteogenic differentiation and bone formation by regulating the Wnt signaling pathway. Knocking down IFITM2 inhibits bone mineralization and osteogenic marker expression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Interferon-inducible transmembrane (IFITM) proteins are known for roles in viral restriction.
  • Recent studies reveal broader functions, including IFITM5 in bone mineralization and IFITM1/3 in muscle differentiation.
  • The specific role of IFITM2 in osteogenesis was previously unclear.

Purpose of the Study:

  • To investigate the role of Interferon-inducible transmembrane protein 2 (IFITM2) in osteogenic differentiation.
  • To elucidate the molecular mechanisms underlying IFITM2's function in bone formation.

Main Methods:

  • Upregulation analysis of Ifitm2 during osteogenic differentiation of C3H10T1/2 cells.
  • siRNA-mediated knockdown of Ifitm2 to assess effects on differentiation and gene expression.
  • Transcriptome analysis of osteoblasts with Ifitm2 knockdown.
  • Luciferase assays to evaluate Wnt signaling pathway activity.
  • Immunohistochemical colocalization studies in mouse bone tissue.

Main Results:

  • Ifitm2 expression was upregulated during osteogenic differentiation, correlating with osteogenic markers (Col1a1, Alp, Runx2, Ocn).
  • Ifitm2 knockdown inhibited osteogenic differentiation, calcium deposition, and expression of osteogenic markers.
  • Knockdown of Ifitm2 altered the expression of Wnt signaling pathway components (Wnt ligands, receptors Lrp/Frizzled/Lgr, Rnf43).
  • Ifitm2 overexpression enhanced canonical Wnt signaling.
  • IFITM2 colocalized with the osteogenic transcription factor SP7 in mouse bone growth plates.

Conclusions:

  • IFITM2 plays a novel and positive role in osteogenic differentiation.
  • IFITM2 promotes bone formation, at least partly, through the regulation of the Wnt signaling pathway.
  • IFITM2 is a potential therapeutic target for bone-related disorders.